ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors

Autor: Mcgeoch, A., van Oordt, C. Menke-van der Houven, Bergstrom, M., McSherry, I., Smith, D., Cleveland, M., Hoekstra, O., Vugts, D., Weber, A., Freedman, I., Huisman, M., Matheny, C., van Dongen, G., Zhang, S.
Přispěvatelé: Medical oncology, CCA - Imaging and biomarkers, CCA - Treatment and quality of life, Clinical chemistry, AGEM - Endocrinology, metabolism and nutrition, AGEM - Inborn errors of metabolism, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Radiology and nuclear medicine, ACS - Heart failure & arrhythmias, AII - Inflammatory diseases, APH - Aging & Later Life, APH - Societal Participation & Health, Epidemiology and Data Science, Amsterdam Neuroscience - Brain Imaging, CCA - Cancer biology and immunology
Jazyk: angličtina
Rok vydání: 2017
Zdroj: Mcgeoch, A, van Oordt, C M D H, Bergstrom, M, McSherry, I, Smith, D, Cleveland, M, Hoekstra, O, Vugts, D, Weber, A, Freedman, I, Huisman, M, Matheny, C, van Dongen, G & Zhang, S 2017, ' ImmunoPET imaging to assess target engagement: Experience from Zr-89-anti-HER3 mAb (GSK2849330) in patients with solid tumors ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, pp. S314-S315 .
European Journal of Nuclear Medicine and Molecular Imaging, 44, S314-S315. Springer Verlag
ISSN: 1619-7070
Databáze: OpenAIRE
Externí odkaz: